Stereotaxis, Inc. (STXS) 10-Year Financial Performance & Capital Metrics

STXS • • Industrial / General

HealthcareMedical InstrumentsSurgical & Interventional DevicesRobotic Surgery Systems

AboutStereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.Show more

Revenue $27M +0.5%
EBITDA -$24M -11.9%
Net Income -$24M -16.1%
EPS (Diluted) -0.30 -11.1%
Gross Margin 54.22% -2.3%
EBITDA Margin -88.31% -11.3%
Operating Margin -91.91% -12.7%
Net Margin -89.33% -15.5%
ROE -144.19% -87.4%
ROIC -289.62% -225.3%
Debt/Equity 0.53 +109.8%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Expensive at 19.1x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-2.59%

5Y-1.41%

3Y-8.4%

TTM19.61%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-9.54%

EPS CAGR

10Y-

5Y-

3Y-

TTM-2.02%

ROCE

10Y Avg-50.68%

5Y Avg-49.35%

3Y Avg-66.56%

Latest-91.99%

Peer Comparison

Robotic Surgery Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ISRGIntuitive Surgical, Inc.	203.04B	572.75	89.21	17.24%	28.58%	16.12%	0.64%	0.01
MBOTMicrobot Medical Inc.	143.05M	2.13	-2.92			-16.71%		0.03
STXSStereotaxis, Inc.	238.91M	2.56	-8.53	0.55%	-78.56%	-204.85%		0.53

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	37.67M	32.16M	31.14M	29.35M	28.9M	26.63M	35.02M	28.15M	26.77M	26.92M
Revenue Growth %	0.08%	-0.15%	-0.03%	-0.06%	-0.02%	-0.08%	0.32%	-0.2%	-0.05%	0.01%
Cost of Goods Sold+	10.44M	7.53M	10.75M	5.72M	6.14M	7.66M	11.79M	9.68M	11.91M	12.32M
COGS % of Revenue	0.28%	0.23%	0.35%	0.19%	0.21%	0.29%	0.34%	0.34%	0.44%	0.46%
Gross Profit+	27.24M	24.63M	20.39M	23.63M	22.77M	18.97M	23.23M	18.47M	14.86M	14.59M
Gross Margin %	0.72%	0.77%	0.65%	0.81%	0.79%	0.71%	0.66%	0.66%	0.56%	0.54%
Gross Profit Growth %	0.02%	-0.1%	-0.17%	0.16%	-0.04%	-0.17%	0.22%	-0.2%	-0.2%	-0.02%
Operating Expenses+	32.65M	31.06M	26.31M	26.09M	27.59M	25.68M	36.12M	37.25M	36.7M	39.33M
OpEx % of Revenue	0.87%	0.97%	0.84%	0.89%	0.95%	0.96%	1.03%	1.32%	1.37%	1.46%
Selling, General & Admin	26.39M	25.57M	21.55M	17.87M	18.57M	17.54M	25.92M	26.69M	26.43M	29.57M
SG&A % of Revenue	0.7%	0.8%	0.69%	0.61%	0.64%	0.66%	0.74%	0.95%	0.99%	1.1%
Research & Development	6.25M	5.49M	4.76M	8.22M	9.02M	8.14M	10.2M	10.56M	10.27M	9.76M
R&D % of Revenue	0.17%	0.17%	0.15%	0.28%	0.31%	0.31%	0.29%	0.38%	0.38%	0.36%
Other Operating Expenses	0	0	212.03K	0	0	0	0	0	0	0
Operating Income+	-5.41M	-6.43M	-5.92M	-2.46M	-4.83M	-6.71M	-12.89M	-18.78M	-21.84M	-24.74M
Operating Margin %	-0.14%	-0.2%	-0.19%	-0.08%	-0.17%	-0.25%	-0.37%	-0.67%	-0.82%	-0.92%
Operating Income Growth %	-0%	-0.19%	0.08%	0.58%	-0.96%	-0.39%	-0.92%	-0.46%	-0.16%	-0.13%
EBITDA+	-4.79M	-5.86M	-5.17M	-1.88M	-4.7M	-6.59M	-12.78M	-18.35M	-21.24M	-23.77M
EBITDA Margin %	-0.13%	-0.18%	-0.17%	-0.06%	-0.16%	-0.25%	-0.36%	-0.65%	-0.79%	-0.88%
EBITDA Growth %	-0.03%	-0.22%	0.12%	0.64%	-1.5%	-0.4%	-0.94%	-0.44%	-0.16%	-0.12%
D&A (Non-Cash Add-back)	620.13K	566.93K	753.68K	579.02K	122.74K	126.21K	106K	429K	595K	969K
EBIT	-5.41M	-6.43M	-5.92M	-2.46M	-4.83M	-6.71M	-12.89M	-18.78M	-21.84M	-24.74M
Net Interest Income+	-3.28M	-2.48M	-179.84K	-16.57K	235.57K	67.36K	-10.07K	484K	1.1M	694K
Interest Income	1.86K	368	0	0	235.57K	67.36K	0	484K	1.1M	694K
Interest Expense	3.28M	2.48M	179.84K	16.57K	0	0	10.07K	0	0	0
Other Income/Expense	-1.94M	1.14M	32.19K	2.57M	235.57K	67.36K	2.17M	484K	1.13M	694K
Pretax Income+	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Pretax Margin %	-0.2%	-0.16%	-0.19%	0%	-0.16%	-0.25%	-0.31%	-0.65%	-0.77%	-0.89%
Income Tax+	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Net Margin %	-0.2%	-0.16%	-0.19%	0%	-0.16%	-0.25%	-0.31%	-0.65%	-0.77%	-0.89%
Net Income Growth %	-0.41%	0.28%	-0.11%	1.02%	-40.32%	-0.45%	-0.61%	-0.71%	-0.13%	-0.16%
Net Income (Continuing)	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.35	-0.24	-0.26	0.00	-0.07	-0.11	-0.16	-0.26	-0.27	-0.30
EPS Growth %	-0.35%	0.31%	-0.08%	1.01%	-	-0.64%	-0.45%	-0.63%	-0.04%	-0.11%
EPS (Basic)	-0.35	-0.24	-0.26	0.00	-0.07	-0.11	-0.16	-0.26	-0.27	-0.30
Diluted Shares Outstanding	21.11M	21.81M	22.61M	52.08M	63.05M	72.75M	75.56M	76.06M	80.7M	85.18M
Basic Shares Outstanding	21.01M	21.81M	22.61M	52.08M	63.05M	72.75M	75.56M	76.06M	80.7M	85.18M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	17.26M	19.4M	9.87M	17.97M	38.83M	52.72M	51.39M	43.25M	33.27M	26.44M
Cash & Short-Term Investments	5.59M	8.5M	3.69M	10.8M	30.18M	43.94M	38.74M	28.43M	19.82M	12.22M
Cash Only	5.59M	8.5M	3.69M	10.8M	30.18M	43.94M	38.74M	8.59M	19.82M	12.22M
Short-Term Investments	0	0	0	0	0	0	0	19.84M	0	0
Accounts Receivable	6.38M	4.67M	4.29M	5.02M	5.33M	3.52M	5.41M	5.09M	3.82M	3.82M
Days Sales Outstanding	61.78	52.95	50.25	62.45	67.31	48.18	56.34	66.01	52.11	51.85
Inventory	4.5M	5.38M	1.15M	1.19M	1.85M	3.3M	4.43M	7.88M	8.43M	8.33M
Days Inventory Outstanding	157.51	260.86	38.93	76.08	109.89	156.94	137.25	297.07	258.21	246.74
Other Current Assets	0	0	0	0	0	250.62K	570K	525K	623K	1.28M
Total Non-Current Assets+	1.97M	1.56M	796.59K	542.06K	4.75M	2.74M	9.6M	10.17M	8.64M	20.29M
Property, Plant & Equipment	1.07M	1.09M	592.69K	343.69K	4.54M	2.43M	8.37M	9.21M	8.29M	9.06M
Fixed Asset Turnover	35.30x	29.61x	52.55x	85.39x	6.37x	10.96x	4.19x	3.05x	3.23x	2.97x
Goodwill	0	0	0	0	0	0	0	0	0	3.76M
Intangible Assets	635.89K	436.57K	159.47K	0	0	0	0	0	0	7.36M
Long-Term Investments	0	0	0	0	0	0	0	0	219K	0
Other Non-Current Assets	264.16K	39.24K	44.43K	198.37K	218.1K	308.51K	1.23M	952K	137K	107K
Total Assets+	19.23M	20.97M	10.67M	18.51M	43.58M	55.46M	60.98M	53.41M	41.91M	46.72M
Asset Turnover	1.96x	1.53x	2.92x	1.59x	0.66x	0.48x	0.57x	0.53x	0.64x	0.58x
Asset Growth %	-0.19%	0.09%	-0.49%	0.74%	1.35%	0.27%	0.1%	-0.12%	-0.22%	0.11%
Total Current Liabilities+	16.14M	35.65M	30.13M	10.19M	12.16M	13.57M	13.26M	14.29M	13.25M	21.6M
Accounts Payable	1.84M	2.62M	1.65M	1.73M	2.1M	1.61M	4.19M	3.27M	3.19M	5.67M
Days Payables Outstanding	64.35	127.16	56.14	110.22	124.86	76.61	129.7	123.34	97.75	167.87
Short-Term Debt	0	0	0	0	0	1.19M	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	794.13K	19.79M	19.57M	0	0	157.62K	0	163K	0	4.59M
Current Ratio	1.07x	0.54x	0.33x	1.76x	3.19x	3.88x	3.87x	3.03x	2.51x	1.22x
Quick Ratio	0.79x	0.39x	0.29x	1.65x	3.04x	3.64x	3.54x	2.47x	1.88x	0.84x
Cash Conversion Cycle	154.94	186.65	33.03	28.31	52.34	128.51	63.9	239.74	212.56	130.72
Total Non-Current Liabilities+	20.71M	842.74K	1.15M	1.05M	2.9M	1.65M	8.3M	7.19M	6.74M	13.69M
Long-Term Debt	18.08M	0	0	0	0	973.25K	0	0	0	0
Capital Lease Obligations	0	0	0	0	2.09M	0	5.84M	5.49M	5.06M	5.44M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	275.6K	320.41K	535.37K	641.46K	255.52K	131.23K	218K	51K	43K	6.19M
Total Liabilities	36.85M	36.5M	31.27M	11.24M	15.06M	15.23M	21.56M	21.48M	19.99M	35.29M
Total Debt+	18.43M	0	0	0	4.34M	4.45M	6.11M	5.86M	5.49M	6.01M
Net Debt	12.84M	-8.5M	-3.69M	-10.8M	-25.84M	-39.49M	-32.63M	-2.73M	-14.33M	-6.21M
Debt / Equity	-	-	-	-	0.15x	0.11x	0.15x	0.18x	0.25x	0.53x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-1.65x	-2.59x	-32.92x	-148.32x	-	-	-1279.71x	-	-	-
Total Equity+	-17.63M	-15.53M	-20.61M	7.27M	28.52M	40.23M	39.42M	31.93M	21.92M	11.43M
Equity Growth %	-0.4%	0.12%	-0.33%	1.35%	2.92%	0.41%	-0.02%	-0.19%	-0.31%	-0.48%
Book Value per Share	-0.83	-0.71	-0.91	0.14	0.45	0.55	0.52	0.42	0.27	0.13
Total Shareholders' Equity	-17.63M	-15.53M	-20.61M	7.27M	28.52M	40.23M	39.42M	31.93M	21.92M	11.43M
Common Stock	21.55K	22.06K	22.81K	59.06K	68.53K	73.69K	75K	75K	81K	85K
Retained Earnings	-465.96M	-471.25M	-477.13M	-476.72M	-481.31M	-487.96M	-498.68M	-516.97M	-537.68M	-561.73M
Treasury Stock	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K
Accumulated OCI	0	-5.96M	-5.96M	-5.96M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-2.53M	-6.56M	-4.67M	-2.55M	-4.62M	-3.51M	-2.95M	-8.41M	-9.14M	-8.5M
Operating CF Margin %	-0.07%	-0.2%	-0.15%	-0.09%	-0.16%	-0.13%	-0.08%	-0.3%	-0.34%	-0.32%
Operating CF Growth %	0.72%	-1.6%	0.29%	0.46%	-0.81%	0.24%	0.16%	-1.86%	-0.09%	0.07%
Net Income	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Depreciation & Amortization	620.13K	566.93K	753.68K	579.02K	122.74K	126.21K	106K	429K	595K	969K
Stock-Based Compensation	1.31M	1.37M	768.68K	560.97K	1.33M	3.17M	9.36M	10.58M	10.62M	10.26M
Deferred Taxes	-890.24K	-3.62M	3.84M	-2.17M	0	0	0	0	0	0
Other Non-Cash Items	222.68K	674.1K	100K	24.66K	2.34M	2.34M	-1.83M	-25K	-256K	1.81M
Working Capital Changes	3.56M	-259.16K	-4.24M	-1.65M	-3.82M	-2.5M	135K	-1.1M	612K	2.5M
Change in Receivables	104.03K	1.71M	378.7K	-733.86K	-308.47K	1.81M	-1.89M	316K	1.27M	691K
Change in Inventory	1.52M	-853.17K	285.41K	-365.14K	-655.86K	-1.45M	-1.14M	-2.91M	-550K	677K
Change in Payables	-513K	782.88K	-968.91K	72.26K	372.74K	-490.46K	1.43M	-169K	218K	758K
Cash from Investing+	-153.15K	-410.18K	-81.58K	-265.48K	-29.49K	-70.9K	-1.4M	-22.09M	19.77M	74K
Capital Expenditures	-153.15K	-410.18K	-81.58K	-265.48K	-29.49K	-70.9K	-1.4M	-2.38M	-366K	-34K
CapEx % of Revenue	0%	0.01%	0%	0.01%	0%	0%	0.04%	0.08%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-153.15M	0	0	0	0	0	0	0	0	0
Cash from Financing+	1M	9.88M	-58.95K	9.92M	24.03M	17.34M	547K	220K	81K	297K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	-100K	-100K	9.86M	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.68M	-6.97M	-4.76M	-2.81M	-4.65M	-3.58M	-4.34M	-10.79M	-9.51M	-8.53M
FCF Margin %	-0.07%	-0.22%	-0.15%	-0.1%	-0.16%	-0.13%	-0.12%	-0.38%	-0.36%	-0.32%
FCF Growth %	0.71%	-1.6%	0.32%	0.41%	-0.65%	0.23%	-0.21%	-1.49%	0.12%	0.1%
FCF per Share	-0.13	-0.32	-0.21	-0.05	-0.07	-0.05	-0.06	-0.14	-0.12	-0.10
FCF Conversion (FCF/Net Income)	0.34x	1.24x	0.79x	-21.81x	1.01x	0.53x	0.27x	0.46x	0.44x	0.35x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	1.61%	-25.65%	-19.33%	-26.91%	-51.27%	-76.93%	-144.19%
Return on Invested Capital (ROIC)	-	-	-	-	-	-294.83%	-256.68%	-78.23%	-89.03%	-289.62%
Gross Margin	72.29%	76.59%	65.47%	80.52%	78.77%	71.22%	66.34%	65.62%	55.51%	54.22%
Net Margin	-19.52%	-16.44%	-18.9%	0.4%	-15.89%	-24.96%	-30.6%	-64.99%	-77.37%	-89.33%
Debt / Equity	-	-	-	-	0.15x	0.11x	0.15x	0.18x	0.25x	0.53x
Interest Coverage	-1.65x	-2.59x	-32.92x	-148.32x	-	-	-1279.71x	-	-	-
FCF Conversion	0.34x	1.24x	0.79x	-21.81x	1.01x	0.53x	0.27x	0.46x	0.44x	0.35x
Revenue Growth	7.61%	-14.63%	-3.17%	-5.77%	-1.51%	-7.86%	31.51%	-19.63%	-4.89%	0.55%

Revenue by Segment

	2013	2014	2015	2016	2017	2018	2022	2023	2024
Disposables, service and accessories	-	-	-	-	-	-	-	-	18.29M
Disposables, service and accessories Growth	-	-	-	-	-	-	-	-	-
Systems	-	-	-	-	-	1.58M	6.84M	8.74M	8.63M
Systems Growth	-	-	-	-	-	-	332.67%	27.67%	-1.22%
Disposables Service and Accessories	-	-	-	-	-	-	-	18.03M	-
Disposables Service and Accessories Growth	-	-	-	-	-	-	-	-	-
Disposables Service And Accessories	-	-	-	-	-	-	21.3M	-	-
Disposables Service And Accessories Growth	-	-	-	-	-	-	-	-	-
Disposables, Service and Accessories	-	-	-	-	-	27.76M	-	-	-
Disposables, Service and Accessories Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2013	2014	2015	2016	2017	2018	2022	2023	2024
Non-US	-	-	-	-	-	-	8.44M	8.57M	13.49M
Non-US Growth	-	-	-	-	-	-	-	1.58%	57.38%
UNITED STATES	-	-	-	-	-	-	19.71M	18.2M	13.43M
UNITED STATES Growth	-	-	-	-	-	-	-	-7.66%	-26.22%
United States	-	-	-	-	-	18.61M	-	-	-
United States Growth	-	-	-	-	-	-	-	-	-
U	24.06M	21.63M	19.76M	19.42M	18.04M	-	-	-	-
U Growth	-	-10.13%	-8.64%	-1.71%	-7.12%	-	-	-	-
Non Us	-	-	17.92M	12.74M	13.11M	-	-	-	-
Non Us Growth	-	-	-	-28.87%	2.84%	-	-	-	-

Frequently Asked Questions

Growth & Financials

Stereotaxis, Inc. (STXS) reported $30.1M in revenue for fiscal year 2024. This represents a 28% decrease from $42.0M in 2011.

Stereotaxis, Inc. (STXS) grew revenue by 0.5% over the past year. Growth has been modest.

Stereotaxis, Inc. (STXS) reported a net loss of $23.6M for fiscal year 2024.

Dividend & Returns

Stereotaxis, Inc. (STXS) has a return on equity (ROE) of -144.2%. Negative ROE indicates the company is unprofitable.

Stereotaxis, Inc. (STXS) had negative free cash flow of $4.3M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Stereotaxis, Inc. (STXS) 10-Year Financial Performance & Capital Metrics

STXS • • Industrial / General

HealthcareMedical InstrumentsSurgical & Interventional DevicesRobotic Surgery Systems

Revenue $27M +0.5%
EBITDA -$24M -11.9%
Net Income -$24M -16.1%
EPS (Diluted) -0.30 -11.1%
Gross Margin 54.22% -2.3%
EBITDA Margin -88.31% -11.3%
Operating Margin -91.91% -12.7%
Net Margin -89.33% -15.5%
ROE -144.19% -87.4%
ROIC -289.62% -225.3%
Debt/Equity 0.53 +109.8%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Negative free cash flow
✗Low quality earnings: Net income not backed by cash flow
✗Expensive at 19.1x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-2.59%

5Y-1.41%

3Y-8.4%

TTM19.61%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-9.54%

EPS CAGR

10Y-

5Y-

3Y-

TTM-2.02%

ROCE

10Y Avg-50.68%

5Y Avg-49.35%

3Y Avg-66.56%

Latest-91.99%

Peer Comparison

Robotic Surgery Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ISRGIntuitive Surgical, Inc.	203.04B	572.75	89.21	17.24%	28.58%	16.12%	0.64%	0.01
MBOTMicrobot Medical Inc.	143.05M	2.13	-2.92			-16.71%		0.03
STXSStereotaxis, Inc.	238.91M	2.56	-8.53	0.55%	-78.56%	-204.85%		0.53

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	37.67M	32.16M	31.14M	29.35M	28.9M	26.63M	35.02M	28.15M	26.77M	26.92M
Revenue Growth %	0.08%	-0.15%	-0.03%	-0.06%	-0.02%	-0.08%	0.32%	-0.2%	-0.05%	0.01%
Cost of Goods Sold+	10.44M	7.53M	10.75M	5.72M	6.14M	7.66M	11.79M	9.68M	11.91M	12.32M
COGS % of Revenue	0.28%	0.23%	0.35%	0.19%	0.21%	0.29%	0.34%	0.34%	0.44%	0.46%
Gross Profit+	27.24M	24.63M	20.39M	23.63M	22.77M	18.97M	23.23M	18.47M	14.86M	14.59M
Gross Margin %	0.72%	0.77%	0.65%	0.81%	0.79%	0.71%	0.66%	0.66%	0.56%	0.54%
Gross Profit Growth %	0.02%	-0.1%	-0.17%	0.16%	-0.04%	-0.17%	0.22%	-0.2%	-0.2%	-0.02%
Operating Expenses+	32.65M	31.06M	26.31M	26.09M	27.59M	25.68M	36.12M	37.25M	36.7M	39.33M
OpEx % of Revenue	0.87%	0.97%	0.84%	0.89%	0.95%	0.96%	1.03%	1.32%	1.37%	1.46%
Selling, General & Admin	26.39M	25.57M	21.55M	17.87M	18.57M	17.54M	25.92M	26.69M	26.43M	29.57M
SG&A % of Revenue	0.7%	0.8%	0.69%	0.61%	0.64%	0.66%	0.74%	0.95%	0.99%	1.1%
Research & Development	6.25M	5.49M	4.76M	8.22M	9.02M	8.14M	10.2M	10.56M	10.27M	9.76M
R&D % of Revenue	0.17%	0.17%	0.15%	0.28%	0.31%	0.31%	0.29%	0.38%	0.38%	0.36%
Other Operating Expenses	0	0	212.03K	0	0	0	0	0	0	0
Operating Income+	-5.41M	-6.43M	-5.92M	-2.46M	-4.83M	-6.71M	-12.89M	-18.78M	-21.84M	-24.74M
Operating Margin %	-0.14%	-0.2%	-0.19%	-0.08%	-0.17%	-0.25%	-0.37%	-0.67%	-0.82%	-0.92%
Operating Income Growth %	-0%	-0.19%	0.08%	0.58%	-0.96%	-0.39%	-0.92%	-0.46%	-0.16%	-0.13%
EBITDA+	-4.79M	-5.86M	-5.17M	-1.88M	-4.7M	-6.59M	-12.78M	-18.35M	-21.24M	-23.77M
EBITDA Margin %	-0.13%	-0.18%	-0.17%	-0.06%	-0.16%	-0.25%	-0.36%	-0.65%	-0.79%	-0.88%
EBITDA Growth %	-0.03%	-0.22%	0.12%	0.64%	-1.5%	-0.4%	-0.94%	-0.44%	-0.16%	-0.12%
D&A (Non-Cash Add-back)	620.13K	566.93K	753.68K	579.02K	122.74K	126.21K	106K	429K	595K	969K
EBIT	-5.41M	-6.43M	-5.92M	-2.46M	-4.83M	-6.71M	-12.89M	-18.78M	-21.84M	-24.74M
Net Interest Income+	-3.28M	-2.48M	-179.84K	-16.57K	235.57K	67.36K	-10.07K	484K	1.1M	694K
Interest Income	1.86K	368	0	0	235.57K	67.36K	0	484K	1.1M	694K
Interest Expense	3.28M	2.48M	179.84K	16.57K	0	0	10.07K	0	0	0
Other Income/Expense	-1.94M	1.14M	32.19K	2.57M	235.57K	67.36K	2.17M	484K	1.13M	694K
Pretax Income+	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Pretax Margin %	-0.2%	-0.16%	-0.19%	0%	-0.16%	-0.25%	-0.31%	-0.65%	-0.77%	-0.89%
Income Tax+	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Net Margin %	-0.2%	-0.16%	-0.19%	0%	-0.16%	-0.25%	-0.31%	-0.65%	-0.77%	-0.89%
Net Income Growth %	-0.41%	0.28%	-0.11%	1.02%	-40.32%	-0.45%	-0.61%	-0.71%	-0.13%	-0.16%
Net Income (Continuing)	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.35	-0.24	-0.26	0.00	-0.07	-0.11	-0.16	-0.26	-0.27	-0.30
EPS Growth %	-0.35%	0.31%	-0.08%	1.01%	-	-0.64%	-0.45%	-0.63%	-0.04%	-0.11%
EPS (Basic)	-0.35	-0.24	-0.26	0.00	-0.07	-0.11	-0.16	-0.26	-0.27	-0.30
Diluted Shares Outstanding	21.11M	21.81M	22.61M	52.08M	63.05M	72.75M	75.56M	76.06M	80.7M	85.18M
Basic Shares Outstanding	21.01M	21.81M	22.61M	52.08M	63.05M	72.75M	75.56M	76.06M	80.7M	85.18M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	17.26M	19.4M	9.87M	17.97M	38.83M	52.72M	51.39M	43.25M	33.27M	26.44M
Cash & Short-Term Investments	5.59M	8.5M	3.69M	10.8M	30.18M	43.94M	38.74M	28.43M	19.82M	12.22M
Cash Only	5.59M	8.5M	3.69M	10.8M	30.18M	43.94M	38.74M	8.59M	19.82M	12.22M
Short-Term Investments	0	0	0	0	0	0	0	19.84M	0	0
Accounts Receivable	6.38M	4.67M	4.29M	5.02M	5.33M	3.52M	5.41M	5.09M	3.82M	3.82M
Days Sales Outstanding	61.78	52.95	50.25	62.45	67.31	48.18	56.34	66.01	52.11	51.85
Inventory	4.5M	5.38M	1.15M	1.19M	1.85M	3.3M	4.43M	7.88M	8.43M	8.33M
Days Inventory Outstanding	157.51	260.86	38.93	76.08	109.89	156.94	137.25	297.07	258.21	246.74
Other Current Assets	0	0	0	0	0	250.62K	570K	525K	623K	1.28M
Total Non-Current Assets+	1.97M	1.56M	796.59K	542.06K	4.75M	2.74M	9.6M	10.17M	8.64M	20.29M
Property, Plant & Equipment	1.07M	1.09M	592.69K	343.69K	4.54M	2.43M	8.37M	9.21M	8.29M	9.06M
Fixed Asset Turnover	35.30x	29.61x	52.55x	85.39x	6.37x	10.96x	4.19x	3.05x	3.23x	2.97x
Goodwill	0	0	0	0	0	0	0	0	0	3.76M
Intangible Assets	635.89K	436.57K	159.47K	0	0	0	0	0	0	7.36M
Long-Term Investments	0	0	0	0	0	0	0	0	219K	0
Other Non-Current Assets	264.16K	39.24K	44.43K	198.37K	218.1K	308.51K	1.23M	952K	137K	107K
Total Assets+	19.23M	20.97M	10.67M	18.51M	43.58M	55.46M	60.98M	53.41M	41.91M	46.72M
Asset Turnover	1.96x	1.53x	2.92x	1.59x	0.66x	0.48x	0.57x	0.53x	0.64x	0.58x
Asset Growth %	-0.19%	0.09%	-0.49%	0.74%	1.35%	0.27%	0.1%	-0.12%	-0.22%	0.11%
Total Current Liabilities+	16.14M	35.65M	30.13M	10.19M	12.16M	13.57M	13.26M	14.29M	13.25M	21.6M
Accounts Payable	1.84M	2.62M	1.65M	1.73M	2.1M	1.61M	4.19M	3.27M	3.19M	5.67M
Days Payables Outstanding	64.35	127.16	56.14	110.22	124.86	76.61	129.7	123.34	97.75	167.87
Short-Term Debt	0	0	0	0	0	1.19M	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	794.13K	19.79M	19.57M	0	0	157.62K	0	163K	0	4.59M
Current Ratio	1.07x	0.54x	0.33x	1.76x	3.19x	3.88x	3.87x	3.03x	2.51x	1.22x
Quick Ratio	0.79x	0.39x	0.29x	1.65x	3.04x	3.64x	3.54x	2.47x	1.88x	0.84x
Cash Conversion Cycle	154.94	186.65	33.03	28.31	52.34	128.51	63.9	239.74	212.56	130.72
Total Non-Current Liabilities+	20.71M	842.74K	1.15M	1.05M	2.9M	1.65M	8.3M	7.19M	6.74M	13.69M
Long-Term Debt	18.08M	0	0	0	0	973.25K	0	0	0	0
Capital Lease Obligations	0	0	0	0	2.09M	0	5.84M	5.49M	5.06M	5.44M
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	275.6K	320.41K	535.37K	641.46K	255.52K	131.23K	218K	51K	43K	6.19M
Total Liabilities	36.85M	36.5M	31.27M	11.24M	15.06M	15.23M	21.56M	21.48M	19.99M	35.29M
Total Debt+	18.43M	0	0	0	4.34M	4.45M	6.11M	5.86M	5.49M	6.01M
Net Debt	12.84M	-8.5M	-3.69M	-10.8M	-25.84M	-39.49M	-32.63M	-2.73M	-14.33M	-6.21M
Debt / Equity	-	-	-	-	0.15x	0.11x	0.15x	0.18x	0.25x	0.53x
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-1.65x	-2.59x	-32.92x	-148.32x	-	-	-1279.71x	-	-	-
Total Equity+	-17.63M	-15.53M	-20.61M	7.27M	28.52M	40.23M	39.42M	31.93M	21.92M	11.43M
Equity Growth %	-0.4%	0.12%	-0.33%	1.35%	2.92%	0.41%	-0.02%	-0.19%	-0.31%	-0.48%
Book Value per Share	-0.83	-0.71	-0.91	0.14	0.45	0.55	0.52	0.42	0.27	0.13
Total Shareholders' Equity	-17.63M	-15.53M	-20.61M	7.27M	28.52M	40.23M	39.42M	31.93M	21.92M	11.43M
Common Stock	21.55K	22.06K	22.81K	59.06K	68.53K	73.69K	75K	75K	81K	85K
Retained Earnings	-465.96M	-471.25M	-477.13M	-476.72M	-481.31M	-487.96M	-498.68M	-516.97M	-537.68M	-561.73M
Treasury Stock	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K	-206K
Accumulated OCI	0	-5.96M	-5.96M	-5.96M	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-2.53M	-6.56M	-4.67M	-2.55M	-4.62M	-3.51M	-2.95M	-8.41M	-9.14M	-8.5M
Operating CF Margin %	-0.07%	-0.2%	-0.15%	-0.09%	-0.16%	-0.13%	-0.08%	-0.3%	-0.34%	-0.32%
Operating CF Growth %	0.72%	-1.6%	0.29%	0.46%	-0.81%	0.24%	0.16%	-1.86%	-0.09%	0.07%
Net Income	-7.35M	-5.29M	-5.89M	116.76K	-4.59M	-6.65M	-10.72M	-18.29M	-20.71M	-24.05M
Depreciation & Amortization	620.13K	566.93K	753.68K	579.02K	122.74K	126.21K	106K	429K	595K	969K
Stock-Based Compensation	1.31M	1.37M	768.68K	560.97K	1.33M	3.17M	9.36M	10.58M	10.62M	10.26M
Deferred Taxes	-890.24K	-3.62M	3.84M	-2.17M	0	0	0	0	0	0
Other Non-Cash Items	222.68K	674.1K	100K	24.66K	2.34M	2.34M	-1.83M	-25K	-256K	1.81M
Working Capital Changes	3.56M	-259.16K	-4.24M	-1.65M	-3.82M	-2.5M	135K	-1.1M	612K	2.5M
Change in Receivables	104.03K	1.71M	378.7K	-733.86K	-308.47K	1.81M	-1.89M	316K	1.27M	691K
Change in Inventory	1.52M	-853.17K	285.41K	-365.14K	-655.86K	-1.45M	-1.14M	-2.91M	-550K	677K
Change in Payables	-513K	782.88K	-968.91K	72.26K	372.74K	-490.46K	1.43M	-169K	218K	758K
Cash from Investing+	-153.15K	-410.18K	-81.58K	-265.48K	-29.49K	-70.9K	-1.4M	-22.09M	19.77M	74K
Capital Expenditures	-153.15K	-410.18K	-81.58K	-265.48K	-29.49K	-70.9K	-1.4M	-2.38M	-366K	-34K
CapEx % of Revenue	0%	0.01%	0%	0.01%	0%	0%	0.04%	0.08%	0.01%	0%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-153.15M	0	0	0	0	0	0	0	0	0
Cash from Financing+	1M	9.88M	-58.95K	9.92M	24.03M	17.34M	547K	220K	81K	297K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	0	-100K	-100K	9.86M	0	0	0	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-2.68M	-6.97M	-4.76M	-2.81M	-4.65M	-3.58M	-4.34M	-10.79M	-9.51M	-8.53M
FCF Margin %	-0.07%	-0.22%	-0.15%	-0.1%	-0.16%	-0.13%	-0.12%	-0.38%	-0.36%	-0.32%
FCF Growth %	0.71%	-1.6%	0.32%	0.41%	-0.65%	0.23%	-0.21%	-1.49%	0.12%	0.1%
FCF per Share	-0.13	-0.32	-0.21	-0.05	-0.07	-0.05	-0.06	-0.14	-0.12	-0.10
FCF Conversion (FCF/Net Income)	0.34x	1.24x	0.79x	-21.81x	1.01x	0.53x	0.27x	0.46x	0.44x	0.35x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	1.61%	-25.65%	-19.33%	-26.91%	-51.27%	-76.93%	-144.19%
Return on Invested Capital (ROIC)	-	-	-	-	-	-294.83%	-256.68%	-78.23%	-89.03%	-289.62%
Gross Margin	72.29%	76.59%	65.47%	80.52%	78.77%	71.22%	66.34%	65.62%	55.51%	54.22%
Net Margin	-19.52%	-16.44%	-18.9%	0.4%	-15.89%	-24.96%	-30.6%	-64.99%	-77.37%	-89.33%
Debt / Equity	-	-	-	-	0.15x	0.11x	0.15x	0.18x	0.25x	0.53x
Interest Coverage	-1.65x	-2.59x	-32.92x	-148.32x	-	-	-1279.71x	-	-	-
FCF Conversion	0.34x	1.24x	0.79x	-21.81x	1.01x	0.53x	0.27x	0.46x	0.44x	0.35x
Revenue Growth	7.61%	-14.63%	-3.17%	-5.77%	-1.51%	-7.86%	31.51%	-19.63%	-4.89%	0.55%

Revenue by Segment

	2013	2014	2015	2016	2017	2018	2022	2023	2024
Disposables, service and accessories	-	-	-	-	-	-	-	-	18.29M
Disposables, service and accessories Growth	-	-	-	-	-	-	-	-	-
Systems	-	-	-	-	-	1.58M	6.84M	8.74M	8.63M
Systems Growth	-	-	-	-	-	-	332.67%	27.67%	-1.22%
Disposables Service and Accessories	-	-	-	-	-	-	-	18.03M	-
Disposables Service and Accessories Growth	-	-	-	-	-	-	-	-	-
Disposables Service And Accessories	-	-	-	-	-	-	21.3M	-	-
Disposables Service And Accessories Growth	-	-	-	-	-	-	-	-	-
Disposables, Service and Accessories	-	-	-	-	-	27.76M	-	-	-
Disposables, Service and Accessories Growth	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2013	2014	2015	2016	2017	2018	2022	2023	2024
Non-US	-	-	-	-	-	-	8.44M	8.57M	13.49M
Non-US Growth	-	-	-	-	-	-	-	1.58%	57.38%
UNITED STATES	-	-	-	-	-	-	19.71M	18.2M	13.43M
UNITED STATES Growth	-	-	-	-	-	-	-	-7.66%	-26.22%
United States	-	-	-	-	-	18.61M	-	-	-
United States Growth	-	-	-	-	-	-	-	-	-
U	24.06M	21.63M	19.76M	19.42M	18.04M	-	-	-	-
U Growth	-	-10.13%	-8.64%	-1.71%	-7.12%	-	-	-	-
Non Us	-	-	17.92M	12.74M	13.11M	-	-	-	-
Non Us Growth	-	-	-	-28.87%	2.84%	-	-	-	-

Frequently Asked Questions

Growth & Financials

Stereotaxis, Inc. (STXS) reported $30.1M in revenue for fiscal year 2024. This represents a 28% decrease from $42.0M in 2011.

Stereotaxis, Inc. (STXS) grew revenue by 0.5% over the past year. Growth has been modest.

Stereotaxis, Inc. (STXS) reported a net loss of $23.6M for fiscal year 2024.

Dividend & Returns

Stereotaxis, Inc. (STXS) has a return on equity (ROE) of -144.2%. Negative ROE indicates the company is unprofitable.

Stereotaxis, Inc. (STXS) had negative free cash flow of $4.3M in fiscal year 2024, likely due to heavy capital investments.